Skip to main content
. 2017 Apr 27;15(2):182–186. doi: 10.5217/ir.2017.15.2.182

Table 3. Multivariate Analysis of the Risk Factors for Recurrence or Aggravation.

Risk factor OR 95% CI P-value
IFX or ADA 6.0 0.855–42.470 0.530
Fistula classification 2.9 0.365–24.493 0.290
Seton 17.2 1.463–202.232 0.007

Logistic regression.

IFX, infliximab; ADA, adalimumab.